Compare INDI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDI | AMPH |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 845.2M | 885.4M |
| IPO Year | 2021 | 2005 |
| Metric | INDI | AMPH |
|---|---|---|
| Price | $3.78 | $22.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $6.25 | ★ $28.38 |
| AVG Volume (30 Days) | ★ 7.7M | 401.4K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.95 | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | $217,394,000.00 | ★ $719,887,000.00 |
| Revenue This Year | $25.54 | $6.90 |
| Revenue Next Year | $38.45 | $4.64 |
| P/E Ratio | ★ N/A | $27.01 |
| Revenue Growth | ★ 0.33 | N/A |
| 52 Week Low | $2.32 | $16.65 |
| 52 Week High | $6.05 | $31.26 |
| Indicator | INDI | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 49.99 | 62.66 |
| Support Level | $3.71 | $18.22 |
| Resistance Level | $4.11 | $22.32 |
| Average True Range (ATR) | 0.34 | 0.61 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 17.22 | 79.65 |
Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.